-
M412306-5mg
MSX-130 (C007B-230583)
Price: $179.85List Price: $199.83InformationMSX-130 MSX-130 is an antagonist of C-X-C chemokine receptor type 4 (CXCR4) .TargetsCXCR4. -
N598331-1mg
NBD C6 ceramide
Price: $972.85List Price: $1,080.95Product introduction:NBD C6 ceramide is a fluorescent sphingolipid analog that can be used to study sphingolipid transport and metabolic mechanisms. It can also be used to selectively stain the Golgi apparatus in living and fixed cells. The -
N-139-1ML
NOSCAPINE-13C D3 HCL
Price: $309.81List Price: $344.23Legal Information CERILLIANT is a registered trademark of Cerilliant Corporation Snap-N-Shoot is a registered trademark of Cerilliant Corporation Snap-N-Spike is a registered trademark of Cerilliant Corporation -
18316-1
NVS-CECR2-1-1 mg
Price: $235.18List Price: $261.31A potent and selective inhibitor of CECR2 (IC<sub>50</sub> = 0.047 µM by Alpha screen, K<sub>d</sub> = 0.80 µM by ITC) shows robust activity in cells, by FRAP assay, due to its slow off-rate. -
18316-5
NVS-CECR2-1-5 mg
Price: $538.71List Price: $598.57A potent and selective inhibitor of CECR2 (IC<sub>50</sub> = 0.047 µM by Alpha screen, K<sub>d</sub> = 0.80 µM by ITC) shows robust activity in cells, by FRAP assay, due to its slow off-rate. -
S-906-1ML
STANOZOLOL1.0áMG/ML IN 1 2-DIMETHOXYETHANE AMPULE OF 1áML CERTIFIED REFERENCE MATERIAL CERILLIANT
Price: $302.25List Price: $335.84General description An analytical reference standard applicable for use in sports testing, urine drug testing, or forensic analysis by LC-MS/MS or GC/MS. Stanozolol is used as a treatment for osteoporosis and steroid-deficiency, but has also been -
S-115-1ML
SUVOREXANT-D6100á?G/ML IN METHANOL CERTIFIED REFERENCE MATERIAL AMPULE OF 1áML CERILLIANT
Price: $428.82List Price: $476.47General description Suvorexant, sold under the trade name Belsomra, is a medication for the treatment of insomnia, approved for sale by the U.S. -
549746-25G
TETRAHYDRO-2-METHYL-3-THIOXO-1 2 4-TRIAZINE- 5 6-DIONE 97%
Price: $712.80List Price: $792.00Tetrahydro-2-methyl-3-thioxo-1,2,4-triazine-5,6-dione is an intermediate for synthesizing ceftriaxone. -
T658841-50mg
Thalidomide-PEG2-NH2 hydrochloride (C007B-431547)
Price: $466.47List Price: $518.31Thalidomide-PEG2-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate ( E3 Ligase Ligand-Linker Conjugates ) that incorporates the Thalidomide ( Thalidomide (HY-14658) ) based cereblon ligand and a linker used in PROTAC -
C1613-25 mg
VEGFR inhibitor. It decreases tumor vascular bed volume in brain metastasis models and lowers lesion number and polyp size in intestinal cancer models. (C003B-255292)
Price: $299.40List Price: $332.66Cediranib is a pan-VEGFR inhibitor that displays anticancer chemotherapeutic and anti-angiogenic activities. Cediranib is currently in clinical trials and displays activity against a wide variety of cancers. -
C1613-100 mg
VEGFR inhibitor. It decreases tumor vascular bed volume in brain metastasis models and lowers lesion number and polyp size in intestinal cancer models. (C003B-255879)
Price: $801.02List Price: $890.02Cediranib is a pan-VEGFR inhibitor that displays anticancer chemotherapeutic and anti-angiogenic activities. Cediranib is currently in clinical trials and displays activity against a wide variety of cancers. -
C1613-250 mg
VEGFR inhibitor. It decreases tumor vascular bed volume in brain metastasis models and lowers lesion number and polyp size in intestinal cancer models. (C003B-256117)
Price: $1,602.85List Price: $1,780.94Cediranib is a pan-VEGFR inhibitor that displays anticancer chemotherapeutic and anti-angiogenic activities. Cediranib is currently in clinical trials and displays activity against a wide variety of cancers.